We recently compiled a list of the Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks. In this article, we are ...

A possibly more precise risk model showed Adempas helped PAH patients at intermediate risk of death arrive at more favorable ...

In a report released today, Chase Knickerbocker from Craig-Hallum assigned a Buy rating to Ironwood Pharma (IRWD – Research Report), with a ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Roivant Sciences Ltd.

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been well-studied, according to Lewis H. Romer, MD, of Johns Hopkins University ...

In particular, endothelium-derived NO, produced by eNOS, is essential for cardiovascular health.Endothelium-derived NO activates soluble guanylate cyclase (sGC) in vascular smooth muscle cells (VSMCs) ...

It is administered through inhalation route as dry powder. The drug candidate acts by targeting soluble guanylate cyclase (sGC). GlobalData, the leading provider of industry intelligence, provided the ...

However, there has been no improvement in exercise capacity in this state despite attempts to restore NO bioavailability by organic nitrate supplementation, phosphodiesterase type 5 inhibition, or ...

A recent clinical trial has shown that riociguat, a medication designed to stimulate the nitric oxide receptor soluble guanylate cyclase, does not increase rates of vaso-occlusive events in patients ...

The drug candidate acts by targeting soluble guanylate cyclase and is administered by oral route. It was also under development for the treatment of women's health. GlobalData, the leading provider of ...

The company is focusing on monetizing its soluble guanylate cyclase (sGC) stimulator assets to generate immediate revenue, which will help support its plans without causing immediate dilution for ...

No direct impact. Works upon arousal mechanisms being active. 2. NO Release Nitric oxide (NO) activates guanylate cyclase, increasing cGMP production. No direct impact. 3. cGMP Production Increased ...